Gan & Lee Pharmaceuticals.
603087
Rangering i aksjer
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Aksjekurs
$10.03
Markedsverdi
$5.99B
Endring (1 dag)
-3.71%
Endring (1 år)
2.30%
Land
CN
Handel Gan & Lee Pharmaceuticals. (603087)
Kategori
Healthcare
Driftsmargin for Gan & Lee Pharmaceuticals. (603087)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Gan & Lee Pharmaceuticals. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Gan & Lee Pharmaceuticals. fra 2013 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2025 | 18.81% | -9.31% |
| 2024 | 20.74% | 71.55% |
| 2023 | 12.09% | -136.39% |
| 2022 | -33.22% | -170.64% |
| 2021 | 47.03% | 8.82% |
| 2020 | 43.22% | -10.50% |
| 2019 | 48.29% | 3.47% |
| 2018 | 46.67% | -12.86% |
| 2017 | 53.56% | 5.43% |
| 2016 | 50.80% | 18.69% |
| 2015 | 42.80% | 14.19% |
| 2014 | 37.48% | 10.99% |
| 2013 | 33.77% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 31.28% | - |
US
|
|
| 12.36% | - |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | - |
US
|
|
| 0.00% | - |
CH
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.